Popular Hypoglycemia News and Current Events | Page 9

Popular Hypoglycemia News and Current Events, Hypoglycemia News Articles.
Sort By: Most Relevant | Most Recent
Page 9 of 9 | 331 Results
New islet cell transplant procedure offers improved outcomes for patients with type 1 diabetes
The latest approach to islet transplantation has produced substantially improved results for patients with type 1 diabetes, and may offer a more durable alternative to a whole pancreas transplant. Participants received islet cells isolated from the pancreas of organ donors to help their bodies produce insulin. The new approach, which allowed the harvested cells a short period of rest prior to transplant, resulted in increased levels of insulin production to the degree that patients were able to discontinue daily insulin injections. (2013-09-19)

Annals of Internal Medicine tip sheet for Oct. 18, 2005
The current issue for the Annals of Internal Medicine includes the following two articles: 1. Two new diabetes treatments may provide options for type 2 diabetes. Lifestyle changes are still the treatments of first defense; 2. New medicare drug programs carry out-of-pocket drug costs, so drug company assistance programs may still be needed. (2005-10-17)

Insulin degludec lowers risk of recurrent low blood sugar or has similar risk to insulin glargine
Insulin degludec, a new ultra-long-acting insulin, has a similar or reduced risk of recurrent hypoglycemia -- low blood sugar -- compared with the commercially available insulin glargine, a new meta-analysis study finds. Results of the combined analysis, of five completed clinical trials, will be presented Tuesday at The Endocrine Society's 95th Annual Meeting in San Francisco. (2013-06-18)

New study shows diabetes patients prefer prefilled NovoLog(R) Mix 70/30 FlexPen(R) disposable pen
In the current issue of Diabetes Care, study results find the NovoLog Mix 70/30 FlexPen was rated higher than prior treatments for type 2 diabetes patients. (2004-09-27)

Alzheimer's and low blood sugar in diabetes may trigger a vicious cycle
Diabetes-associated episodes of low blood sugar may increase the risk of developing dementia, while having dementia or even milder forms of cognitive impairment may increase the risk of experiencing low blood sugar, according to a UC San Francisco scientist who led a new study published online June 10 in JAMA Internal Medicine. (2013-06-10)

Treating pregnant women for mild gestational diabetes reduces serious birthing problems
Treating pregnant women for mild gestational diabetes resulted in fewer cesarean sections and other serious birthing problems associated with larger than average babies, according to a study conducted in part at the University of North Carolina at Chapel Hill. (2009-09-30)

In a post-hoc analysis, elderly patients with type 2 diabetes experienced less hypoglycemia and similar blood sugar reductions with JANUVIA compared to sulfonylurea
Merck (known as MSD outside the United States and Canada) today announced results of a post-hoc pooled analysis in which patients with Type 2 diabetes age 65 or older treated with JANUVIA (sitagliptin) 100 mg/day achieved similar blood sugar reductions as those treated with a sulfonylurea, with significantly less hypoglycemia (low blood sugar). (2012-06-09)

News tips from the Journal of Neuroscience
The following articles are featured in the Sept. 17 issue of the Journal of Neuroscience: (2008-09-16)

Animas makes progress in development of a first-generation closed-loop insulin delivery system
Animas Corporation announced today further promising results from the second phase of human clinical trials of a first-generation closed-loop insulin delivery system in development. Data investigating the predictive Hypoglycemia-Hyperglycemia Minimizer System demonstrated that the system is capable of maintaining safe glucose levels overnight. The data was presented at the 73rd Scientific Sessions of the American Diabetes Association in Chicago, Illinois. (2013-06-21)

Takeda's investigational DPP-4 inhibitor demonstrated efficacy
Data on Alogliptin, a highly selective dipeptidyl peptidase-IV (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes, was announced at the 67th Scientific Sessions of the American Diabetes Association meeting in Chicago. (2007-06-25)

Joslin Diabetes Center study examines insulin pump therapy in adolescents
Joslin study shows durability of insulin pump therapy for adolescents and identifies factors to help them overcome barriers to success. (2006-10-31)

Page 9 of 9 | 331 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.